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Primary localized amyloidosis of the airways is an uncommon disorder characterized by amyloid deposits
in the airway mucosa. In contrast to systemic amyloidosis other organs are not involved. Among the
entities of airway amyloidosis, tracheobronchial amyloidosis is comparatively the most common subtype
in the lower respiratory tract and laryngeal amyloidosis in the upper respiratory tract. The pathophys-
iology of localized airway amyloidosis is poorly understood. The clinical presentation is variable and
often non-speciﬁc. No general consensus exists with regard to optimal treatment resulting in a variety of
modalities used in clinical practice to manage this disorder. We report the case of a 50 year old woman
with multifocal localized amyloidosis of the tracheobronchial tree and the upper airways. Tracheo-
bronchial amyloidosis was treated with endoscopic debulking and external beam radiation, sinunasal
amyloid deposits were surgically excised and are currently under surveillance. The importance of this
extremely rare case lies in the multifocal presentation of an uncommon disorder requiring a multidis-
ciplinary approach to offer optimal treatment including external beam radiation.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Background
Primary isolated amyloidosis involving the respiratory tract is a
rare disease. It mostly affects the trachea and central bronchi [1,2],
but amyloid deposits in other sections of the airways alone or in
combination with tracheobronchial amyloidosis (TBA) have been
reported [3e5]. TBA is typically not associated with systemic
amyloidosis or pulmonary parenchymal deposits such as in Sjog-
ren's syndrome. It represents a localized variant of amyloidosis and
is characterized by multiple amyloid deposits within the airway
walls [6].
The diagnosis of TBA is often delayed, as affected patients have
signs and symptoms not differ from common airway diseases.
Pulmonary function tests may or may not reveal an obstructive
pattern. Chest x-rays are frequently unremarkable or a tracheal
mass is overlooked. On computer tomography, diffuse TBA leads to, Department of respiratory
any.
. Lang), dagmar.taeuscher@
(J. Füller), andreas.mueller@
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Ltd. This is an open access article uconcentric smooth or nodular thickening of the submucosal
tracheal wall. The diagnosis of TBA is made by means of bron-
choscopy and biopsy of airway mucosa [1,7,8].
Management of this disease is directed at maintaining airway
patency, but no general consensus exists with regard to optimal
treatment, as debridement is often associated with severe and
prolonged bleeding.
We report the case of a 50 year old woman with concurrent
amyloidosis of the tracheobronchial tree and the upper airways.
Our case illustrates the necessity for a multidisciplinary approach,
including respiratory medicine and otorhinolaryngology, radiology,
pathology and radiotherapy to achieve an accurate and timely
diagnosis of this uncommon disorder and to offer currently optimal
therapy.
2. Case presentation
A 50 year old woman was admitted to the hospital for bron-
choscopic evaluation. She was an active smoker with a cigarette
smoking history of 30 pack years and had suffered from repeated
bronchitis, shortage of breath and hoarseness as well as repeated
episodes of hemoptysis. She also complained of nasal congestionnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 2. Pulmonary function test showing an expiratory plateau in the ﬂow volume loop
(arrows).
Fig. 3. Prominent white and reddish plaques and diffuse bleeding of the mucosa of the
right upper lobe bronchi.
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lobe had not resolved after antibiotic treatment.
On clinical examination, stridor was audible in the central air-
ways. The physical examination of other organ systems was not
remarkable. Laboratory investigations included normal blood
count, normal erythrocyte sedimentation rate and normal
biochemistry. A computer tomography scan revealed an atelectasis
of the right upper lobe and diffuse nodular thickening of the sub-
mucosal tracheal and bronchial walls (Fig. 1). The cartilage showed
calciﬁcations. There were no other parenchymal abnormalities.
Arterial blood gases, while breathing room air, were normal. Pul-
monary function tests revealed normal FVC, FEV1, FEV1/FVC; but
decreased PEF and an expiratory plateau in the ﬂow volume loop,
suggestive of intrathoracic stenosis (Fig. 2).
Flexible bronchoscopy was performed and a completely irreg-
ular surface of the tracheal and bronchial mucosa with prominent
white and reddish plaques, extending the lower half of the trachea
and main bronchi with reduced airway diameters and diffuse
bleeding was found (Fig. 3). Biopsies showed amorphous deposits,
identiﬁed as amyloid by apple-green birefringence in sections
stained with congo red and seen under polarized light. Immuno-
histochemical staining demonstrated AL amyloid. Systemic
amyloidosis was excluded by normal serum protein electropho-
resis, normal urine analyses (no Bence Jones protein in the urin),
normal rectal biopsy specimens, normal bone marrow aspiration/
biopsy, normal echocardiography and abdominal ultrasound.
The patient underwent bronchoscopic debridement with forceps
debulking for more extensive bioptic work-up and treatment of
airway stenosis. The procedure was complicated by prolonged but
self-limited bleeding. The casewas discussed at themultidisciplinary
respiratory oncology board and it was felt that external beam radi-
ation therapy (EBRT) was an appropriate treatment option. Radiation
therapy was explained in detail to the patient because of the scarcity
of clinical data regarding its use for TBA. She received EBRT, 20 Gy in
10 fractions. Opposed anterio-posterior and posterior-anterior
treatment ﬁelds were used to encompass the entire tracheobron-
chial tree. The treatment volume was determined using CT-guided
simulation. Treatment was uneventful. Clinically her symptoms
improved and the pulmonary function test stabilized during 12
month follow-up. Chest x-rays at 6 months and CT scans at 12
months after radiation therapy revealed that response to radiation
was maintained, with no evidence of disease progression.
Meanwhile the symptoms of chronic sinusitis and nasal
congestion worsened. She was transferred to the department ofFig. 1. Computer tomography scan revealing diffuse nodular thickening of the bron-
chial walls (arrows).Otolaryngology/Head and Neck Surgery where a CT scan revealed a
mass at the bottom of the left maxillary sinus and the nasopharynx.
Surgical excision conﬁrmed amyloid deposits submucosally at the
roof of the nasopharynx. Functional endoscopic sinus surgery
(FEES) was performed to ventilate the left maxillary sinus. To date
no further treatment has been necessary.3. Discussion
Amyloidosis restricted to the respiratory tract is a rare mani-
festation of an otherwise rare disorder. Less than 250 cases of
pulmonary amyloidosis have been reported, predominantly as
anecdotal reports or small series [1,2]. Localized pulmonary
amyloidosis can manifest as parenchymal nodules, diffuse alveolar
septal disease, or mostly tracheobronchial disease. Isolated nasal
amyloidosis is extremely uncommon, some 20 cases have been
reported in the literature [4,5,9e13]. Only a few cases with multi-
focal amyloidosis of the upper and lower airways have been
described. By deﬁnition, localized amyloidosis affects only one or-
gan system and inevitably occurs without systemic amyloidosis. It
is not understood, why these disease processes are limited to the
respiratory tract, but it has been proposed that light chains are
deposited locally by plasma cells.
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30% of patients with TBA may not survive beyond seven to twelve
years after diagnosis [6] due to narrowing airways. There is no
established treatment for TBA. Review of the literature shows that
information about TBA is limited to small case series or case re-
ports. Generally, the treatment options, as gathered from published
data, can be categorized into 4 not necessarily exclusive groups: [1]
systemic pharmacologic treatment, [2] bronchoscopic recanalisa-
tion techniques [3] the use of external beam radiation therapy and
[4] surgery in a few cases.
Pharmacologic treatment with colchicine has been tried,
although the evidence for its use is based on non-controlled trials
that have suggested that adjuvant treatment in primary systemic
amyloidosis may have some beneﬁt. Systemic intermittent
chemotherapy using melphalan and prednisolone has been pre-
scribed with limited success and there is no proof, that pharma-
cologic treatment following repeated laser resection is synergistic
[8,14].
Bronchoscopic debulking with forceps or laser can be effective
for a short time [12,15], but does not slow down the underlying
disease process. Bronchoscopic recanalization techniques are
limited by severe bleeding [16] and the near inevitability of short
term recurrence of the amyloid deposits.
Based on small series and few case reports, it appears that ra-
diation therapy may change the progressive course of TBA [17e24].
EBRT is now recommended as a ﬁrst -line therapy in patients with
bulky or distal disease that is not amenable for bronchoscopic
recanalization, especially if there is evidence of severe symptoms or
functional decline. The successful use of radiation therapy for the
treatment of TBAwas ﬁrst described by Kurrus et al. as a case report
in 1998 [24]. A patient with life-threatening airway obstruction
secondary to TBA received 20 Gy in 10 fractions to the distal and
right main bronchi and 6 months later to the lower lobe bronchi. In
both areas treated the patient responded radiologically and
symptomatically. The beneﬁts of EBRT were maintained in anec-
dotal cases for more than 5 years [18,20]. The mechanisms under-
lying the therapeutic effects of EBRT are unknown. Generally,
patients treated with EBRT achieve a rapid symptomatic response
as well as an objective improvement of pulmonary function tests,
CT scan ﬁndings and bronchoscopic appearance. EBRT was well
tolerated. However, the long-term effects of radiation therapy are
still unknown in these patients and only few patients received a
second course.
4. Conclusions
TBA remains a rare and clinically challenging condition. The
treatment of this disease needs to be evaluated on a case by case
basis and managed with an appropriate multidisciplinary team
including the evaluation of the upper airways. EBRT is a promising
and well tolerated treatment option. Close follow-up to detect late
re-occurrence of the disorder or complications of EBRT is required.
5. Consent
Written informed consent was obtained from the patient for
publication of this Case report and any accompanying images. A
copy of the written consent is available for review by the Editor-in-
Chief of this journal.
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